908 Devices Inc. 8K

908 Devices Inc. announced strong Q2 2026 revenue growth, improved profitability metrics, a solid cash position, and raised the low end of its full-year 2026 revenue outlook to $68–70 million.

908 Devices Inc. reported its second quarter 2026 results, highlighting a 23% year-over-year revenue increase to $16.1 million driven by VipIR product sales and initial NIRLab contributions, improved adjusted gross margins, and a more than 50% reduction in adjusted EBITDA loss to $1.9 million, while maintaining a strong cash position of $101.5 million with no debt and modestly raising the low end of its full-year 2026 revenue guidance range to $68–70 million, implying 21–25% growth over 2025. The company also noted robust demand from U.S. state and local agencies, international VipIR shipments including to a major South Asia law enforcement agency, and a $6 million ProtectIR order from an Asia-Pacific corrections agency booked after quarter end, alongside continued use of non-GAAP metrics such as adjusted gross profit and adjusted EBITDA to evaluate core operating performance.

Filing Facts

CIK

1555279

Ticker

-

Form

8K

Source Type

sec

Accession

0001104659-26-093717

Alert Tier

7